Guardant Health Boosts 2024 Revenue Outlook
Company Announcements

Guardant Health Boosts 2024 Revenue Outlook

Guardant Health ( (GH) ) has released its Q3 earnings. Here is a breakdown of the information Guardant Health presented to its investors.

Guardant Health is a precision oncology company specializing in advanced blood and tissue tests to improve cancer outcomes. Founded in 2012, it uses real-world data and AI analytics to enhance patient care and accelerate cancer therapies.

Related Articles
TheFlyClosing Bell Movers: AppLoving up 29% after Q3 earnings beat
TheFlyGuardant Health reports Q3 EPS (45c), consensus (74c)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App